Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2023-08-22 | Robert Froman Williamson, III has been a director of the Company since February 5, 2023... The current members of the Audit Committee are Ms. Henson (Chair), Mr. Williamson and Dr. Morich... The current members of the Compensation Committee are Mr. Williamson (Chair), Ms. Woods and Ms. Henson... The current members of the Nominations and Corporate Governance Committee are Dr. Morich (Chair), Ms. Woods and Mr. Williamson... Board Committees and Meetings... Robert Froman Williamson, III: Member of Board, Member of Audit Committee, Chair of Compensation Committee, Member of Nominations and Corporate Governance Committee... During the six-month transition period ended December 31, 2022 and the fiscal year ended June 30, 2022, each non-employee director received a cash retainer of $5,000 per month... In February 2023, the Compensation Committee approved changes to the non-employee director compensation program to provide (i) $60,000 annual cash retainer; (iii) additional annual cash retainers for committee chairs equal to $15,000... |
| 2024-04-18 | Mr. Williamson received a BA in economics from Pomona College and an MBA from Stanford University. Our Board of Directors believes that Mr. Williamson’s active involvement in building biotechnology and related technology companies for over two decades qualifies him to serve on our Board. |
Data sourced from SEC filings. Last updated: 2025-08-30